SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 55.06-2.9%Dec 26 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: A.J. Mullen who wrote (51006)7/29/2019 1:28:50 PM
From: DewDiligence_on_SI  Read Replies (1) of 52153
 
The [GHDX] premium doesn't seem very enticing to me even if the current price is slightly inflated due to news leaking. Previously the run up of GHDX was ascribed to it joining an index on Monday.
The 15% pop on 7/24/19 seems excessive for a mere index shuffle, but some people were satisfied that it was the full explanation (e.g. finance.yahoo.com ). With hindsight,I think we can surmise that the small nominal deal premium (5%, based on 7/26/19 closing prices) was due to news leakage.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News